XV
Xvivo Perfusion AB (publ)
XVIPF · OTC
$30.95 +0.00% (+$0.00)
Market Cap 9.35B kr
P/E Ratio 105.88x
Div. Yield -
ROE 5.37%
Bulios Fair Price
$23.74
23.3% downside
Trenutna cena
$30.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XVIPF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive EV/EBITDA 50.89x
P/S 10.49x
P/B 41.25x
Growth
83 /100
Growing Rev. growth 24.95%
Book val. growth 13.81%
EPS growth 8.87%
Profitability
76 /100
Strong Net margin 9.91%
Op. margin 12.23%
FCF margin 15.92%
Quality
77 /100
Excellent ROE 5.37%
ROA 34.03%
Asset turnover 3.43x
Debt
100 /100
Low Current ratio 3.86x
Int. coverage 36.09x
Net debt/EBITDA -0.10x
Stability
35 /100
Moderate Rev. volatility 24.59%
EPS volatility 244.38%
Profitable years 5
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XVIPF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Christoffer Rosenblad
Employees
210
Headquarters
Mölndal
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report